Boehringer Ingelheim is on board!
We are thrilled to annouce that Boeheringer Ingelheim has decided to partner with INNOVATEChina 2022 as industrial partner!!! As one of the leading pharmaceutical companies in the world, Boehringer Ingelheim constantly seeking new territories and continuing their commitment to innovation.
About Boeheringer Ingelheim
Boehringer Ingelheim is one of the top biopharmaceutical companies in the world. Headquartered in Ingelheim Germany, the company operates presently with a total of more than 52,000 employees. Making new and better medicines for humans and animals is at the heart of what we do.
Boehringer Ingelheim China is headquartered in Shanghai with more than 4,000 employees. The major business focuses of Boehringer Ingelheim China includes human pharma, animal health and biopharmaceuticals. In recent years, the company has achieved continuous growth, outperformed the market average. Boehringer Ingelheim China has been certified as “China Top Employer” during 2014 to 2022. China is one of the company’s most important strategic markets. China’s needs have been incorporated into the company’s global R&D strategy. The company aims to bring more and better innovative products earlier to the Chinese patients, contribute to the high-quality development of China’s healthcare industry, and comprehensively improve the health of human and animals. For more information, please visit: https://www.boehringer-ingelheim.com or https://www.boehringer-ingelheim.cn.